SKIN REPLACEMENT MARKET ANALYSIS
Key developments
Increasing number of approvals for novel skin treatment procedures is expected to facilitate growth of the global skin replacement market over the forecast period.
For instance, in September 2018, the U.S. FDA granted premarket approval for Recell (Avita), which is a spray-on treatment for burns in patients older than 18 years.
Moreover, increasing focus on research and development activities by key players is projected to drive the market growth in the future. For instance, in October 2018, Platelet BioGenesis announced that they are in the process of developing a device that imitates the conditions under which human platelets are generated, for patients recovering from injuries, surgery, or treatments like chemotherapy that can lead to an extremely low platelet count.
Moreover, in January 2019, Proctor & Gamble launched Opté, which is a tool aimed at covering skin conditions such as hyperpigmentation, and age spots by simply gliding the device over the skin’s surface. Such product innovations are likely to benefit growth of the skin replacement market.
Need a Custom Report?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize NowWant to Buy a Report but have a Limited Budget?
We help clients to procure the report or sections of the report at their budgeted price. Kindly click on the below to avail
Request Discount
Credibility and Certifications
9001:2015
27001:2022
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients